132 related articles for article (PubMed ID: 22357443)
1. Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies.
Li Y; Jiang T; Zhang J; Zhang B; Yang W; You G; Xu K; Wu J; Luo C; Song SW
Ann Oncol; 2012 Sep; 23(9):2415-2422. PubMed ID: 22357443
[TBL] [Abstract][Full Text] [Related]
2. Letter to the editor concerning 'Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies'.
Hassan WA; Bjerre M; Hjortebjerg R; Magnusson NE; Ramshanker N; Frystyk J
Ann Oncol; 2015 Jan; 26(1):252-253. PubMed ID: 25355718
[No Abstract] [Full Text] [Related]
3. Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer.
Zhang Y; Ying X; Han S; Wang J; Zhou X; Bai E; Zhang J; Zhu Q
Int J Oncol; 2013 Jan; 42(1):93-100. PubMed ID: 23165420
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer.
Liou JM; Shun CT; Liang JT; Chiu HM; Chen MJ; Chen CC; Wang HP; Wu MS; Lin JT
J Clin Endocrinol Metab; 2010 Apr; 95(4):1717-25. PubMed ID: 20157191
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum IGFBP-3 in colorectal cancer.
Hou YL; Luo P; Ji GY; Chen H
J Clin Lab Anal; 2019 Jul; 33(6):e22912. PubMed ID: 31218761
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
Miraki-Moud F; Jenkins PJ; Fairclough PD; Jordan S; Bustin SA; Jones AM; Lowe DG; Monson JP; Grossman AB; Besser GM; Camacho-Hübner C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):499-508. PubMed ID: 11318786
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
8. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer.
el Atiq F; Garrouste F; Remacle-Bonnet M; Sastre B; Pommier G
Int J Cancer; 1994 May; 57(4):491-7. PubMed ID: 7514152
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
Renehan AG; Toogood AA; Ryder WD; Jones J; Potten CS; O'Dwyer ST; Shalet SM
Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study.
Pankaj J; Kumari JR; Kim W; Lee SA
Asian Pac J Cancer Prev; 2015; 16(9):3735-40. PubMed ID: 25987030
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
12. Circulating insulin-like growth factor II and colorectal adenomas.
Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
[TBL] [Abstract][Full Text] [Related]
13. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D
Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
[TBL] [Abstract][Full Text] [Related]
14. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
15. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
16. High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels.
Lancaster JM; Sayer RA; Blanchette C; Calingaert B; Konidari I; Gray J; Schildkraut J; Schomberg DW; Marks JR; Berchuck A
Int J Gynecol Cancer; 2006; 16(4):1529-35. PubMed ID: 16884361
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
19. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
